Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters Jenaker Consulting
Jean Duteau )Duteau Design
John Hatem (Scribe)Independent Consultantx
Scott Robertson (Scribe)Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCP
Isaac VetterEpic
Smile CDR


Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDPx
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealandx
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHA
Tim McNeilSurescripts
Kim RobertsPharmacy HIT Collaborative
Kent BulzaWell Health
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  • - No meeting 

Workflow Update (John Hatem) 

  • - discussed Contract resources
    • per Lloyd, substantive Workflow FHIR changes have been entered for the patterns.  John H will evaluate to determine Pharmacy resource impact. 

Healthcare Product Update (John Hatem)

  • - Tracker work and analysis.  No Pharmacy impact. 

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  • - Scott to follow up

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at

WG18 Patient Consent TG:

  •   - out for HL7 ballot


Pharmacist Consult Note (Scott)

  • - out for HL7 ballot

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • FHIR-36701: Motion to accept resolution related to Adherence in tracker as proposed by Scott R and Jean D.  Motion by:  John Hatem/MargaretWeiker  5-0-0 motion passed.  See tracker for details.  
  • FHIR-37337: Waste: Scott proposed that we move this to Considered for Future Use.  Brief discussion of several use cases and suggestion was to accept this proposition.  No vote was made and this issue will still be discussed at the Sept WGM.   
    • John H asked how would we address the common use case of "wasting" some of the narcotic that was not used in a specific administration?  

Any Other Business:

  • Margaret asked about an email that came from the Pharmacy list serve that talks about a meeting on 8/23 re: PIE WG Bi-weekly meeting (for Pharmacy) - Requested by Green, Christol

Next meeting: